Difficult Conditions in China: Smith & Nephew Lowers Sales Forecast

The British medical technology manufacturer Smith & Nephew has revised its forecast for annual sales growth downward. The originally expected growth of 5% to 6% has been lowered to 4.5%. The main reason for this adjustment is cited as the company's challenges in the surgical business in China, which have proven to be more persistent than initially anticipated. The reduction in the forecast comes at a time when many companies in the medical technology industry are grappling with geopolitical and economic uncertainties, which are also being felt in Asian markets. Consequently, Smith & Nephew, like other competitors, is faced with the task of acting flexibly in a dynamic market environment to still achieve the company's goals. Despite the difficulties, the focus remains on long-term development and innovation to meet both patient needs and demanding market conditions.